Cooper Companies (NASDAQ:COO) Rating Increased to Buy at Wall Street Zen

Cooper Companies (NASDAQ:COO) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

COO has been the topic of a number of other reports. Mizuho set a $100.00 target price on Cooper Companies and gave the stock an “outperform” rating in a research note on Friday, December 5th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Barclays set a $98.00 target price on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, January 26th. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a report on Friday, December 5th. Finally, Stifel Nicolaus set a $95.00 price objective on Cooper Companies and gave the company a “buy” rating in a research note on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $90.77.

Cooper Companies Price Performance

Cooper Companies stock opened at $83.67 on Friday. Cooper Companies has a 52 week low of $61.78 and a 52 week high of $92.84. The company’s 50 day moving average price is $82.27 and its two-hundred day moving average price is $75.70. The stock has a market cap of $16.32 billion, a P/E ratio of 44.51, a P/E/G ratio of 2.40 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period last year, the business posted $1.04 earnings per share. Cooper Companies’s revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, equities analysts predict that Cooper Companies will post 3.98 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Cynthia L. Lucchese acquired 1,784 shares of Cooper Companies stock in a transaction that occurred on Monday, December 22nd. The stock was bought at an average price of $84.06 per share, with a total value of $149,963.04. Following the completion of the purchase, the director owned 9,445 shares in the company, valued at approximately $793,946.70. The trade was a 23.29% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Lawrence Erik Kurzius bought 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The shares were purchased at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the acquisition, the director directly owned 7,777 shares in the company, valued at $641,602.50. This trade represents a 34.62% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 16,014 shares of company stock valued at $1,304,416 in the last three months. Insiders own 1.98% of the company’s stock.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently made changes to their positions in the business. River Road Asset Management LLC increased its stake in Cooper Companies by 1.0% in the 4th quarter. River Road Asset Management LLC now owns 1,582,867 shares of the medical device company’s stock worth $129,732,000 after acquiring an additional 16,103 shares during the last quarter. Kera Capital Partners Inc. purchased a new position in shares of Cooper Companies during the fourth quarter worth about $216,000. Axxcess Wealth Management LLC increased its position in shares of Cooper Companies by 37.1% in the fourth quarter. Axxcess Wealth Management LLC now owns 9,980 shares of the medical device company’s stock worth $818,000 after purchasing an additional 2,698 shares during the last quarter. Corient Private Wealth LLC raised its stake in Cooper Companies by 17.0% in the fourth quarter. Corient Private Wealth LLC now owns 25,699 shares of the medical device company’s stock valued at $2,106,000 after purchasing an additional 3,738 shares in the last quarter. Finally, Alberta Investment Management Corp bought a new stake in Cooper Companies during the fourth quarter valued at approximately $1,582,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.